Free Trial
→ Trump’s Exec Order #14154 could be a “Millionaire-Maker” (From Paradigm Press) (Ad) Free TVTX Stock Alerts

Travere Therapeutics (TVTX) SEC Filings & 10K Form

Travere Therapeutics logo
$15.30 +0.70 (+4.79%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$15.17 -0.13 (-0.85%)
As of 07/8/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Travere Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/02/2025
4:28 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Orwin John A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Bruhn Suzanne Louise (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		COUGHLIN TIMOTHY (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		LYONS GARY A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Poole Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Squarer Ron (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Williams Brinkley Ruth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
2:13 PM		ARMISTICE CAPITAL, LLC (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
05/15/2025
9:47 AM		Rock Springs Capital Management LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
05/15/2025
5:18 AM		MACQUARIE GROUP LTD (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
05/14/2025
10:48 AM		JANUS HENDERSON GROUP PLC (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G
05/05/2025
8:51 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
8:52 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
8:53 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
8:53 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
8:54 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
6:41 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
6:45 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
10:32 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
10:20 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
9:08 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
4:21 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K/A
04/14/2025
5:23 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
6:03 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:57 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
7:36 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
8:10 AM		Rock Springs Capital Management LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
8:27 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:28 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:30 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:22 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:23 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:25 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
6:46 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
6:47 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
10:03 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
8:52 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
10:56 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
"I'm risking my reputation on this" (Ad)

Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.

Claim your FREE copy of Crypto Revolution now.
02/11/2025
6:05 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
5:04 PM		Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
6:44 AM		MACQUARIE GROUP LTD (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
02/05/2025
12:23 PM		BlackRock, Inc. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
02/04/2025
7:30 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
7:40 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
7:41 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
7:46 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
7:47 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
11:26 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
10:11 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
10:22 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
9:09 AM		Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/23/2025
7:35 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:36 PM		Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:37 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:39 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:40 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:31 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:33 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:14 PM		Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
9:34 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
9:18 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
8:36 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:30 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
6:21 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
6:47 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:13 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
8:00 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:59 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
8:46 AM		Deep Track Capital, LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
11/08/2024
3:55 PM		MORGAN STANLEY (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
11/08/2024
3:11 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 424B5
11/04/2024
12:55 PM		Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
7:36 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
7:41 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 424B5
10/31/2024
7:05 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
10:59 AM		STATE STREET CORP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
10/04/2024
6:15 PM		LYONS GARY A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:38 PM		Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:22 PM		Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
5:29 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:05 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
09/09/2024
8:20 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
9:54 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
9:34 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
9:35 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
8:30 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:TVTX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...
Crypto 101 Media | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored